SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041398
Filing Date
2023-08-10
Accepted
2023-08-10 16:31:36
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmra-20230630.htm   iXBRL 10-Q 2381446
2 EX-31.1 cmra-ex31_1.htm EX-31.1 26487
3 EX-31.2 cmra-ex31_2.htm EX-31.2 26551
4 EX-32.1 cmra-ex32_1.htm EX-32.1 17623
5 EX-32.2 cmra-ex32_2.htm EX-32.2 16949
  Complete submission text file 0000950170-23-041398.txt   8594428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20230630_lab.xml EX-101.LAB 483988
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmra-20230630_cal.xml EX-101.CAL 46623
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20230630.xsd EX-101.SCH 74774
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20230630_pre.xml EX-101.PRE 383485
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20230630_def.xml EX-101.DEF 252299
72 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20230630_htm.xml XML 1367022
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41403 | Film No.: 231160082
SIC: 2834 Pharmaceutical Preparations